Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.

Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM.

Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1908-16. doi: 10.1007/s00259-011-1853-6. Epub 2011 Jun 9.

PMID:
21656246
2.

Advances in pharmacologic stress agents: focus on regadenoson.

Johnson SG, Peters S.

J Nucl Med Technol. 2010 Sep;38(3):163-71. doi: 10.2967/jnmt.109.065581. Epub 2010 Aug 19. Review.

3.

Regadenoson in the detection of coronary artery disease.

Buhr C, Gössl M, Erbel R, Eggebrecht H.

Vasc Health Risk Manag. 2008;4(2):337-40. Review.

4.

Regadenoson: a new myocardial stress agent.

Al Jaroudi W, Iskandrian AE.

J Am Coll Cardiol. 2009 Sep 22;54(13):1123-30. doi: 10.1016/j.jacc.2009.04.089. Review. Erratum in: J Am Coll Cardiol. 2009 Oct 20;54(17):1635.

5.

Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.

Palani G, Ananthasubramaniam K.

Cardiol Rev. 2013 Jan-Feb;21(1):42-8. doi: 10.1097/CRD.0b013e3182613db6. Review.

PMID:
22643345
6.

Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.

Parodi O, Neglia D, Sambuceti G, Marabotti C, Palombo C, Donato L.

Drugs. 1992;44 Suppl 1:48-55. Review.

PMID:
1283584
7.
8.

PET: Is myocardial flow quantification a clinical reality?

Saraste A, Kajander S, Han C, Nesterov SV, Knuuti J.

J Nucl Cardiol. 2012 Oct;19(5):1044-59. doi: 10.1007/s12350-012-9588-8. Review.

PMID:
22733534
9.

Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health.

Schindler TH, Schelbert HR, Quercioli A, Dilsizian V.

JACC Cardiovasc Imaging. 2010 Jun;3(6):623-40. doi: 10.1016/j.jcmg.2010.04.007. Review.

10.

PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation.

Gewirtz H.

J Nucl Cardiol. 2012 Apr;19(2):347-54. doi: 10.1007/s12350-011-9510-9. Review.

PMID:
22231036
11.

Regadenoson.

Bengalorkar GM, Bhuvana K, Sarala N, Kumar TN.

J Postgrad Med. 2012 Apr-Jun;58(2):140-6. doi: 10.4103/0022-3859.97177. Review.

12.

Quantitative assessment of myocardial blood flow--clinical and research applications.

Schindler TH, Quercioli A, Valenta I, Ambrosio G, Wahl RL, Dilsizian V.

Semin Nucl Med. 2014 Jul;44(4):274-93. doi: 10.1053/j.semnuclmed.2014.04.002. Review.

PMID:
24948151
13.

Selective adenosine agonists and myocardial perfusion imaging.

Zoghbi GJ, Iskandrian AE.

J Nucl Cardiol. 2012 Feb;19(1):126-41. doi: 10.1007/s12350-011-9474-9. Review.

PMID:
22130964
14.

Regadenoson: a focused update.

Ghimire G, Hage FG, Heo J, Iskandrian AE.

J Nucl Cardiol. 2013 Apr;20(2):284-8. doi: 10.1007/s12350-012-9661-3. Review.

PMID:
23229649
15.

Advances in pharmacologic agents in imaging: new A2A receptor agonists.

Cerqueira MD.

Curr Cardiol Rep. 2006 Mar;8(2):119-22. Review.

PMID:
16524538
16.

The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.

Valenta I, Dilsizian V, Quercioli A, Schelbert HR, Schindler TH.

Curr Cardiol Rep. 2012 Apr;14(2):217-25. doi: 10.1007/s11886-011-0240-z. Review.

PMID:
22205177
17.

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Golzar Y, Doukky R.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 22;9:129-37. doi: 10.2147/COPD.S56879. eCollection 2014. Review.

18.

Quantitative myocardial blood flow with Rubidium-82 PET: a clinical perspective.

Hagemann CE, Ghotbi AA, Kjær A, Hasbak P.

Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):457-68. eCollection 2015. Review.

19.

Adenosine receptors as drug targets--what are the challenges?

Chen JF, Eltzschig HK, Fredholm BB.

Nat Rev Drug Discov. 2013 Apr;12(4):265-86. doi: 10.1038/nrd3955. Review.

20.

Quantitative cardiac positron emission tomography: the time is coming!

Sciagrà R.

Scientifica (Cairo). 2012;2012:948653. doi: 10.6064/2012/948653. Epub 2012 Aug 27. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk